Summary
High costs have limited the uptake of weight-loss drugs in emerging markets, with penetration rates below 0.1% in China and 0.2% in India, but this is expected to change.
Weight-loss drug boom in China, India, Brazil could create US$22bil market by 2035
Source & full coverage: this summary is aggregated from Free Malaysia Today Business, the original publisher. Read the complete report for full context, data and quotes.
Read the original report at Free Malaysia Today Business →
